Cencora Inc’s (NYSE:COR), formerly AmerisourceBergen Corporation, first quarter 2024 adjusted EPS reached $3.28, up from $2.71 Y/Y, beating the consensus of $2.89. In the first quarter ...

On an adjusted basis, Cencora, formerly known as AmerisourceBergen, reported first-quarter profit of $3.73 per share, compared to analysts' estimates of $3.50 per share. Sign up here. Wall Street ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about ... formerly known as AmerisourceBergen, and other businesses in the last four years to raise ...

COR insiders have traded $COR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales. Here’s a ...

Walgreens and Cencora have been working together since 2013, when the drug distributor was still known as AmerisourceBergen. But recently Walgreens has been winnowing its stake in Cencora as the ...

Representatives for Florida Cancer Specialists, Cardinal Health and McKesson declined to comment, while a spokesperson for Cencora, previously known as AmerisourceBergen, didn’t immediately ...

Peer Cardinal Health also raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit. On an adjusted ...